Español
India
Italiano
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
GH Research
GHRS
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$11.66
-0.33
-2.75%
At Close: -
$11.99
0.33
2.83%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Watch
GH Research (GHRS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for GH Research (NASDAQ:GHRS) Stock
GH Research Stock (NASDAQ: GHRS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 05, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Shares of psychedelics companies are trading ...
Benzinga Newsdesk
Tuesday, May 07, 2024
HC Wainwright & Co. Reiterates Buy on GH Rese...
Benzinga Newsdesk
Monday, May 06, 2024
Canaccord Genuity Maintains Buy on GH Researc...
Benzinga Newsdesk
Friday, May 03, 2024
GH Research Q1 EPS $(0.15) Beats $(0.22) Esti...
Benzinga Newsdesk
Wednesday, April 17, 2024
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
HC Wainwright & Co. Reiterates Buy on GH Rese...
Benzinga Newsdesk
Friday, March 01, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Thursday, February 29, 2024
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
Lara Goldstein
GH Research: Q4 Earnings Insights
Benzinga Insights
GH Research Reports FY23 Net Loss Of $(35.6)M...
Benzinga Newsdesk
Thursday, February 15, 2024
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein
Saturday, January 27, 2024
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein
Friday, January 26, 2024
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein
Thursday, January 18, 2024
GH Research Announces Grant Of European Paten...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on GH Rese...
Benzinga Newsdesk
Friday, January 12, 2024
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Lara Goldstein
Monday, January 08, 2024
Psyched: Psychedelics For Brain Injury, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, $50M For Atai And More
Lara Goldstein
Thursday, January 04, 2024
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
Lara Goldstein
Monday, January 01, 2024
Psychedelic Stock Gainers And Losers From January 1, 2024
Benzinga Insights
Wednesday, December 27, 2023
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Lara Goldstein
Monday, December 18, 2023
Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
Lara Goldstein
Stifel Maintains Buy on GH Research, Lowers P...
Benzinga Newsdesk
Monday, December 11, 2023
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
Lara Goldstein
Tuesday, December 05, 2023
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Lara Goldstein
Friday, November 24, 2023
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
Lara Goldstein
Thursday, November 23, 2023
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, November 22, 2023
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
HP, Iridium Communications And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
Tuesday, November 14, 2023
GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
Lara Goldstein
HC Wainwright & Co. Maintains Buy on GH Resea...
Benzinga Newsdesk
Sunday, November 12, 2023
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
Lara Goldstein
Thursday, November 09, 2023
GH Research Q3 EPS $(0.11) Beats $(0.20) Esti...
Benzinga Newsdesk
Monday, November 06, 2023
Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
Lara Goldstein
Sunday, October 29, 2023
Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoir And More
Lara Goldstein
Wednesday, October 25, 2023
General Dynamics, Microsoft, Waste Management And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
Sunday, October 22, 2023
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
Lara Goldstein
Monday, October 16, 2023
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Lara Goldstein
Friday, October 06, 2023
Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
Lara Goldstein
Monday, October 02, 2023
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
Lara Goldstein
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Lara Goldstein
Tuesday, September 26, 2023
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Lara Goldstein
Monday, September 18, 2023
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
Lara Goldstein
Monday, September 11, 2023
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Lara Goldstein
Tuesday, September 05, 2023
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Lara Goldstein
Monday, August 28, 2023
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
Lara Goldstein
Thursday, August 24, 2023
GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
Lara Goldstein
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
